Several biopharmaceutical firms, specialised chemical laboratories, and Active Pharmaceutical Ingredient (API) manufacturers supply standardised psychedelic compounds for clinical trials and laboratory evaluation. These organisations produce compounds such as psilocybin and ibogaine under strict quality and regulatory controls to support pharmaceutical research and therapeutic development.
PsyLabs is one such manufacturer, producing pharmaceutical-grade psychedelic APIs through advanced cultivation, extraction, purification, and manufacturing processes. As a federally licensed producer and exporter, PsyLabs supplies regulated psychedelic compounds to qualified research institutions, pharmaceutical companies, and clinical development programmes worldwide.
